The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
As biotech and pharma drug developers work to bring life-changing therapies to patients as quickly as possible, they must also consider the unique needs of their molecules and the ever-evolving demands of the market. Many companies are prioritizing patient-friendly formats such as oral solid dose (OSD) drugs or sterile injectables to ensure safe and effective delivery. However, OSD development comes with challenges—most notably, solubility and bioavailability.
Lipid formulations, particularly softgels, offer a powerful solution to this challenge and provide several advantages worth considering. Read our article to learn why softgels are a technology of choice—including benefits such as improved bioavailability, efficient API use, ease of scale-up, versatility across development stages, and consumer preference. You’ll also discover why early development is the best time to address solubility and bioavailability issues head-on.
